Stock screener

RLMD

Conviction 61HealthcareScan · Thu, Jun 25, 2026
RLMD$6.43-1.23%
ResistanceSupportVol 14
63 bars
Vol MA14 2.16M
Mar 26Apr 14May 1May 19Jun 8Jun 25
RELMADA THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.relmada.com
Price6.43
Change-1.23%
Gap-0.38%
Rel volume4.54×
Avg volume1.8M
Avg $ vol11.66M
SMA 206.54
SMA 506.97
SMA 2004.71
Price vs 50-7.72%
Price vs 200+36.48%
MA stackmixed
50/200 cross
Supertrenddown · 7.11
RSI (14)45
MACD hist0.03
MACD crossbull · 6d
Stoch %K / %D53 / 63
ADX (14)15
+DI / −DI21 / 21
RSI divergence
MACD divergence
ATR %+6.59%
ADR %6.18%
52w high7.86
52w low0.5362
From 52w high-18.19%
Above 52w low+1099.18%
New 52w highNo
SqueezeOff
Bollinger width21.85%
%B0.43
Donchian pos46.47%
Donchian high7.34
Donchian low5.64
AVWAP (52w high)6.71
vs AVWAP high-4.13%
AVWAP (52w low)4.81
vs AVWAP low+33.57%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d4.54×
Avg vol (14d)2.16M
Avg vol (20d)1.8M
Avg $ vol (20d)11.66M
Market cap674.44M
RS 3m (vs SPY)-5.54%
RS 6m (vs SPY)+41.92%
RS line new highNo
Trend template6/8
Technical rank62.4
1 week-2.58%
1 month-10.32%
3 months-3.45%
6 months+43.21%
1 year+986.33%
YTD+47.14%
P/E-11.75
P/B3.08
P/S
P/FCF-14.73
EPS-1.45
Div yield
ROE-26.24%
ROA-24.38%
Debt/Eq
Current18.26
EV/EBITDA
Gross margin21.31%
Net margin
Rev growth-35.41%
EPS growth28.25%
Price target14.33
Target upside122.86%
Analyst ratingBuy
Institutional81.65%
Ent. value664.67M
Revenue682
Net income-19.05M
Gross profit-3
Free cash flow-45.79M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out104.89M
Employees17
ListedMon, Mar 3, 2014
Free float91.98M
Float %87.7%
Short interest5.84M
Days to cover6.1d
Short volume52.1%
Squeeze score61 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.21 · 2 est
Last EPS vs est−$0.22 vs −$0.18
Last surprise-22.2% miss
Setup gradeB
Conviction61 / 100
Pattern quality
Tech rank62.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance7.90
Support5.88
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RLMD

All disclosures →
No recent disclosed trades by Congress in RLMD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RLMD

No recent insider (Form 4) filings in RLMD. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in RLMD · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.